Curatis reports record first half with 51% revenue jump, advances drug candidate
Curatis Holding AG posted its strongest first half ever with net sales of CHF 7.9 million, a 51% increase year-on-year. The company also reported a narrowed loss of CHF -0.4 million and advanced its corticorelin program with a Japan license deal.